2021/4 GaBI Journal Table of Contents


Editor’s Letter

Fourth and final issue of GaBI Journal’s 10th volume

Original Research

Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices

Review Article

The European framework for intellectual property rights for biological medicines

Biotechnological therapies and biosimilars for COVID-19: scarcities, poor regulation, and pharmaceutical black market: a case analysis in Ecuador


Source URL: http://gabi-journal.net/2021-4-gabi-journal-table-of-contents.html

Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048